Deborah A. Smith

6.8k citations

119 papers · 5.0k · 1 hit paper · h-index 36

Impact in

Oncology top 2%
- HER2/EGFR in Cancer Research
Rheumatology top 1%
- Eosinophilic Disorders and Syndromes

Papers in

Oncology 39
- Colorectal Cancer Treatments and Studies 20
- HER2/EGFR in Cancer Research 15
- Cancer Treatment and Pharmacology 14
Molecular Biology 36
- PI3K/AKT/mTOR signaling in cancer 9

Co-authors: Janet Quinn (13 shared papers)Brian A. Morgan (8 shared papers)Alistair J. P. Brown (5 shared papers)Susan M. Nicholls (2 shared papers)Kevin M. Koch (16 shared papers)Robert K. Wayne (5 shared papers)Neil L. Spector (8 shared papers)Katherine Ralls (7 shared papers)
Journals: Journal of Clinical Oncology (24 papers)Blood (5 papers)Clinical Cancer Research (4 papers)Annals of Oncology (3 papers)British Journal of Clinical Pharmacology (3 papers)
Partner nations: United States United Kingdom Netherlands

In The Last Decade

Deborah A. Smith

112 papers receiving 4.9k citations

Deborah A. Smith's Hit Papers

align trajectories log scale

Phase I Safety, Pharmacokinetics, and Clinical Activity Study of Lapatinib (GW572016), a Reversible Dual Inhibitor of Epidermal Growth Factor Receptor Tyrosine Kinases, in Heavily Pretreated Patients With Metastatic Carcinomas 2005 · 503 citations

Peers

Countries citing papers authored by Deborah A. Smith

Since Specialization

Citations

This map shows the geographic impact of Deborah A. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah A. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah A. Smith more than expected).

Fields of papers citing papers by Deborah A. Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah A. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah A. Smith. The network helps show where Deborah A. Smith may publish in the future.

Co-authors

The 25 scholars most cited alongside Deborah A. Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Deborah A. Smith Line = papers co-authored together Deborah A. Smith links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 119 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Phase I Safety, Pharmacokinetics, and Clinical Activity Study of Lapatinib (GW572016), a Reversible Dual Inhibitor of Epidermal Growth Factor Receptor Tyrosine Kinases, in Heavily Pretreated Patients With Metastatic Carcinomas Journal of Clinical Oncology ·Howard A. Burris, Herbert I. Hurwitz, Elizabeth Claire Dees, Afshin Dowlati, Kimberly Blackwell, Bert H. O’Neil, P. Kelly Marcom, Matthew J. Ellis, Beth Overmoyer, Suzanne F. Jones, Jennifer L. Harris, Deborah A. Smith, Kevin M. Koch, Andrew G. Stead, Steve Mangum, Neil L. Spector Hit paper breakdown →	2005	503
2	Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial Gut ·Alex Straumann, Sébastien Conus, Pascale Grzonka, H. Kita, G M Kephart, Christian Bussmann, Christoph Beglinger, Deborah A. Smith, Jessal J. Patel, Mitchell K. Byrne, Hans‐Uwe Simon	2009	436
3	An Antibody Against IL-5 Reduces Numbers of Esophageal Intraepithelial Eosinophils in Children With Eosinophilic Esophagitis Gastroenterology ·Amal Assa’ad, Sandeep K. Gupta, Margaret H. Collins, Mike Thomson, Amy Heath, Deborah A. Smith, T. Perschy, Cynthia H. Jurgensen, Héctor Ortega, Seema S. Aceves	2011	325
4	Role of the Hog1 Stress-activated Protein Kinase in the Global Transcriptional Response to Stress in the Fungal PathogenCandida albicans Molecular Biology of the Cell ·Brice Enjalbert, Deborah A. Smith, Michael Cornell, Intikhab Álam, Susan M. Nicholls, Alistair J. P. Brown, Janet Quinn	2005	311
5	Study of the Biologic Effects of Lapatinib, a Reversible Inhibitor of ErbB1 and ErbB2 Tyrosine Kinases, on Tumor Growth and Survival Pathways in Patients With Advanced Malignancies Journal of Clinical Oncology ·Neil L. Spector, Wenle Xia, Howard A. Burris, Herbert I. Hurwitz, E. Claire Dees, Afshin Dowlati, Bert H. O’Neil, Beth Overmoyer, P. Kelly Marcom, Kimberly Blackwell, Deborah A. Smith, Kevin M. Koch, Andrew G. Stead, Steven Mangum, Matthew J. Ellis, Lei-Hua Liu, Albert K. Man, Troy Bremer, Jennifer L. Harris, Sarah Bacus	2005	290
6	A Conserved Stress-activated Protein Kinase Regulates a Core Stress Response in the Human Pathogen Candida albicans Molecular Biology of the Cell ·Deborah A. Smith, Susan M. Nicholls, Brian A. Morgan, Alistair J. P. Brown, Janet Quinn	2004	219
7	Detection and accuracy rates of dogs trained to find scats of San Joaquin kit foxes (Vulpes macrotis mutica) Animal Conservation ·Deborah A. Smith, Katherine Ralls, Aimee Hurt, Brice Adams, Megan Parker, Barbara J. Davenport, Marie C. Smith, Jesús E. Maldonado	2003	140
8	Phase I Study of GSK461364, a Specific and Competitive Polo-like Kinase 1 Inhibitor, in Patients with Advanced Solid Malignancies Clinical Cancer Research ·David Olmos, Douglas S. Barker, Rohini Sharma, André T. Brunetto, Timothy A. Yap, Anne B. Taegtmeyer, Jorge Barriuso, Hanine Medani, Yan Degenhardt, Alicia J. Allred, Deborah A. Smith, Sharon C. Murray, Thomas A. Lampkin, Mohammed M. Dar, Richard H. Wilson, Johann S. de Bono, Sarah P. Blagden	2011	134
9	The Use of Microsatellite Variation to Infer Population Structure and Demographic History in a Natural Model System Genetics ·David B. Goldstein, Gary W. Roemer, Deborah A. Smith, David Reich, Aviv Bergman, Robert K. Wayne	1999	131
10	The novel AKT inhibitor afuresertib shows favorable safety, pharmacokinetics, and clinical activity in multiple myeloma Blood ·Andrew Spencer, Sung‐Soo Yoon, Simon J. Harrison, Shannon R. Morris, Deborah A. Smith, Richard A. Brigandi, Jennifer Gauvin, Rakesh Kumar, Joanna Opalinska, Christine Chen	2014	108
11	Thioredoxin Regulates Multiple Hydrogen Peroxide-Induced Signaling Pathways in Candida albicans Molecular and Cellular Biology ·Alessandra da Silva Dantas, Miranda Patterson, Deborah A. Smith, Donna M. MacCallum, Lars P. Erwig, Brian A. Morgan, Janet Quinn	2010	99
12	Phase I pharmacokinetic studies evaluating single and multiple doses of oral GW572016, a dual EGFR-ErbB2 inhibitor, in healthy subjects Investigational New Drugs ·Aimee K. Bence, Eric B. Anderson, Maqbool Halepota, Michael Doukas, Phillip A. DeSimone, George A. Davis, Deborah A. Smith, Kevin M. Koch, Andrew G. Stead, Steve Mangum, Carolyn J. Bowen, Neil L. Spector, Showchien Hsieh, Val R. Adams	2004	98
13	A Single MAPKKK Regulates the Hog1 MAPK Pathway in the Pathogenic FungusCandida albicans Molecular Biology of the Cell ·Jill Cheetham, Deborah A. Smith, Alessandra da Silva Dantas, Kathryn S. Doris, Miranda Patterson, Catherine R. Bruce, Janet Quinn	2007	92
14	The behavioural ecology of the island fox (Urocyon littoralis) Journal of Zoology ·Gary W. Roemer, Deborah A. Smith, David K. Garcelon, Robert K. Wayne	2001	88
15	Stress signalling to fungal stress-activated protein kinase pathways FEMS Microbiology Letters ·Deborah A. Smith, Brian A. Morgan, Janet Quinn	2010	86
16	First-in-Human Phase I Study of GSK2126458, an Oral Pan-Class I Phosphatidylinositol-3-Kinase Inhibitor, in Patients with Advanced Solid Tumor Malignancies Clinical Cancer Research ·Pamela N. Münster, Rahul Aggarwal, David S. Hong, Jan H.M. Schellens, Ruud van der Noll, Jennifer M. Specht, Petronella O. Witteveen, Theresa L. Werner, Elizabeth Claire Dees, Emily K. Bergsland, Neeraj Agarwal, Joseph F. Kleha, M. Durante, Laurel M. Adams, Deborah A. Smith, Thomas A. Lampkin, Shannon R. Morris, Razelle Kurzrock	2015	83
17	A Phase I and Pharmacokinetic Study of Oral Lapatinib Administered Once or Twice Daily in Patients with Solid Malignancies Clinical Cancer Research ·Howard A. Burris, Charles W. Taylor, Suzanne F. Jones, Kevin M. Koch, M. Versola, Niki Arya, Ronald A. Fleming, Deborah A. Smith, Lini Pandite, Neil L. Spector, George Wilding	2009	83
18	Molecular Genetics of Pre‐1940 Red Wolves Conservation Biology ·Michael Roy, Eli Geffen, Deborah A. Smith, Robert K. Wayne	1996	78
19	Pharmacokinetics and Pharmacodynamics of Mepolizumab, an Anti-Interleukin-5 Monoclonal Antibody Clinical Pharmacokinetics ·Deborah A. Smith, Elisabeth A. Minthorn, Misba Beerahee	2011	76
20	Mechanisms Underlying the Exquisite Sensitivity of Candida albicans to Combinatorial Cationic and Oxidative Stress That Enhances the Potent Fungicidal Activity of Phagocytes mBio ·Despoina Kaloriti, Mette D. Jacobsen, Zhikang Yin, Miranda Patterson, Anna Tillmann, Deborah A. Smith, Emily A. Cook, Tao You, Melissa Grimm, Iryna Bohovych, Celso Grebogi, Brahm H. Segal, Neil A. R. Gow, Ken Haynes, Janet Quinn, Alistair J. P. Brown	2014	73

About Deborah A. Smith

Deborah A. Smith is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Infectious Diseases and Ecology, having authored 119 papers that have together received 5.0k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (20 papers), HER2/EGFR in Cancer Research (15 papers), Cancer Treatment and Pharmacology (14 papers), Lung Cancer Treatments and Mutations (12 papers), Wildlife Ecology and Conservation (11 papers), Chronic Lymphocytic Leukemia Research (11 papers), Antifungal resistance and susceptibility (10 papers) and PI3K/AKT/mTOR signaling in cancer (9 papers). The work is most often cited by research in Oncology (1.5k citations), Rheumatology (658 citations), Infectious Diseases (751 citations), Genetics (337 citations) and Immunology (526 citations). Deborah A. Smith has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Janet Quinn, Brian A. Morgan, Alistair J. P. Brown, Susan M. Nicholls, Kevin M. Koch, Robert K. Wayne, Neil L. Spector, Katherine Ralls, Andrew G. Stead and Howard A. Burris. Their work appears in journals such as Journal of Clinical Oncology, Blood, Clinical Cancer Research, Annals of Oncology and British Journal of Clinical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Deborah A. Smith

Impact in

Papers in i

In The Last Decade

Deborah A. Smith

Deborah A. Smith's Hit Papers

Peers

Countries citing papers authored by Deborah A. Smith

Fields of papers citing papers by Deborah A. Smith

All Works

About Deborah A. Smith

Explore authors with similar magnitude of impact

Papers in